SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CVTX - CV Therapeutics, Inc.
An SI Board Since January 1999
Posts SubjectMarks Bans
411 31 0
Emcee:  Todd N. Weisrock Type:  Unmoderated
Introduction Compact
Individual Investor's Special Situations Report featured this stock as their February 1999 pick. The stock closed today at $5 1/2. This company is developing 3 compounds for treatment of cardiovascular diseases. I wanted to open up a thread to discuss this stock with the rest of you all.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
411Bioorg Med Chem Lett. 2009 Jun 1;19(11):3063-6. Epub 2009 Apr 8. Aryl sulfonamidscaram(o)uche-6/25/2009
410Message 25738952scaram(o)uche-6/25/2009
409Wonder if they were really thinking about it or just rumors to goose the stocks fred hayes-3/16/2009
408Astellas Pharma of Japan said on Monday that it was withdrawing its hostile bid mopgcw-3/16/2009
407Wouldn't have guessed that, but now that I'm looking at a stock price infred hayes-3/12/2009
406do you believe in a Japanese counter offer...mopgcw-3/12/2009
405Just noticed cvtx closed above the offer. Not done here?fred hayes-3/12/2009
404Thanks George, that was just a good guess. If I had to make another I'd guefred hayes-3/12/2009
403Any other dead-on predictions Fred?? Please do share... mucho gracias..mopgcw-3/12/2009
402Great news - will rescue what's been a fairly miserable month for me so far.Biomaven-3/12/2009
401Now we need one of the now-small-caps, formerly-star-players to get taken out...scaram(o)uche-3/12/2009
400Didn't really stick in out.... Johnny come lately. Now YOU stuck it out! scaram(o)uche-3/12/2009
399WOW. left a few chips on the table I guess.. cool stuff. congrats on stickinmopgcw-3/12/2009
398Gilead Sciences Agrees to Acquire CV Therapeutics for $20.00 Per Share - Deal toscaram(o)uche-3/12/2009
397Astellas to Make Hostile Bid to Acquire CV Therapeutics Article By HIROYUKI KACmopgcw-3/1/2009
396citi: 20 February 2009 - 8 pages CV Therapeutics Inc (CVTX) mopgcw-2/28/2009
395Out of their pukin' collective mind. By 27 March, Astellas will hold 0.0% oscaram(o)uche-2/27/2009
394Astellas Files Lawsuit against CV Therapeutics Friday February 27, 2009, 10:05 ascaram(o)uche-2/27/2009
393Not new, but new to me so parking..... J Pharmacol Exp Ther. 2008 Jun;325(3):87scaram(o)uche-2/26/2009
392<i> What is with these brits and why do they have to have their gob smackemopgcw-1/28/2009
391"gob-smacked" -- what a cool word. I'm saving that one, will try fred hayes-1/28/2009
390I could see Lange signing up a US marketing partner tomorrow and including a starkrw-1/28/2009
389My guess is that there will not be a second bidder. But the obvious reason for kenhott-1/28/2009
388In this market environment, I find it difficult to believe a bidding war will enmopgcw-1/28/2009
387Seems clear cvtx will be sold (at least to me). Issue is price. I'm still gufred hayes-1/28/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News